Franklin Resources’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-100,646
Closed -$873K 3224
2025
Q3
$873K Sell
100,646
-8,589
-8% -$66.8K ﹤0.01% 2174
2025
Q2
$688K Hold
109,235
﹤0.01% 2181
2025
Q1
$700K Buy
109,235
+16,792
+18% +$139K ﹤0.01% 2123
2024
Q4
$743K Sell
92,443
-4,719
-5% -$45.5K ﹤0.01% 2122
2024
Q3
$1.23M Buy
97,162
+72,894
+300% +$941K ﹤0.01% 1900
2024
Q2
$307K Buy
24,268
+271
+1% +$2.73K ﹤0.01% 2422
2024
Q1
$115K Buy
23,997
+343
+1% +$1.59K ﹤0.01% 2689
2023
Q4
$114K Sell
23,654
-183
-0.8% -$1.12K ﹤0.01% 2456
2023
Q3
$173K Buy
23,837
+249
+1% +$1.99K ﹤0.01% 2358
2023
Q2
$175K Buy
+23,588
New +$185K ﹤0.01% 2414
2023
Q1
Sell
-184,551
Closed -$1.9M 2369
2022
Q4
$1.9M Sell
184,551
-1,598
-0.9% -$28.2K ﹤0.01% 1377
2022
Q3
$3.39M Sell
186,149
-49,736
-21% -$2.16M ﹤0.01% 1185
2022
Q2
$12.1M Sell
235,885
-1,727
-0.7% -$89.5K 0.01% 902
2022
Q1
$17.5M Sell
237,612
-370,872
-61% -$33.1M 0.01% 883
2021
Q4
$87.1M Sell
608,484
-464,064
-43% -$79.7M 0.03% 494
2021
Q3
$222M Sell
1,072,548
-27,114
-2% -$5.98M 0.08% 275
2021
Q2
$233M Sell
1,099,662
-205,748
-16% -$37.7M 0.09% 257
2021
Q1
$237M Buy
1,305,410
+27,121
+2% +$5.4M 0.1% 240
2020
Q4
$143M Sell
1,278,289
-969,382
-43% -$103M 0.06% 330
2020
Q3
$244M Sell
2,247,671
-768,753
-25% -$93.6M 0.12% 205
2020
Q2
$442M Buy
3,016,424
+1,290,399
+75% +$49.4M 0.23% 118
2020
Q1
$23.4M Buy
+1,726,025
New +$14.6M 0.02% 639
2019
Q1
Sell
-234,568
Closed -$8.63M 1521
2018
Q4
$8.63M Sell
234,568
-51,020
-18% -$1.98M 0.01% 893
2018
Q3
$10.7M Hold
285,588
0.01% 917
2018
Q2
$7.65M Hold
285,588
﹤0.01% 969
2018
Q1
$12M Buy
285,588
+114,125
+67% +$4.58M 0.01% 894
2017
Q4
$4.25M Hold
171,463
﹤0.01% 1089
2017
Q3
$3.91M Hold
171,463
﹤0.01% 1104
2017
Q2
$3.94M Sell
171,463
-102,705
-37% -$2.02M ﹤0.01% 1116
2017
Q1
$7.02M Hold
274,168
﹤0.01% 1040
2016
Q4
$6.91M Hold
274,168
﹤0.01% 1035
2016
Q3
$11.4M Hold
274,168
0.01% 947
2016
Q2
$39.9M Buy
274,168
+12,840
+5% +$1.47M 0.02% 597
2016
Q1
$27M Buy
261,328
+109,185
+72% +$11.7M 0.01% 729
2015
Q4
$25.5M Hold
152,143
0.01% 759
2015
Q3
$21.5M Sell
152,143
-18,040
-11% -$4.05M 0.01% 823
2015
Q2
$37.9M Buy
170,183
+2,540
+2% +$446K 0.02% 703
2015
Q1
$27.7M Hold
167,643
0.01% 808
2014
Q4
$19.9M Sell
167,643
-13,020
-7% -$1.36M 0.01% 879
2014
Q3
$15.1M Sell
180,663
-29,360
-14% -$2.65M 0.01% 958
2014
Q2
$19.4M Buy
210,023
+17,500
+9% +$1.54M 0.01% 879
2014
Q1
$17.4M Buy
192,523
+28,515
+17% +$3.19M 0.01% 888
2013
Q4
$16.8M Buy
164,008
+14,008
+9% +$990K 0.01% 862
2013
Q3
$9.48M Buy
+150,000
New +$8.45M 0.01% 982

Other funds holding NVAX

Franklin Resources's NVAX Position: Q4 2025 in Review

Franklin Resources sold out of Novavax (NVAX) in Q4 2025, closing a stake of 100,646 shares — an estimated $873K sold.

Franklin Resources first reported a position in NVAX in Q3 2013 and held it in 44 quarters. The position peaked at $442M in Q2 2020. 234 funds tracked by Wall St. Rank hold NVAX as of Q4 2025.

  • Franklin Resources reported no remaining Novavax position as of Q4 2025 after selling out during the quarter.
  • Franklin Resources sold 100,646 Novavax shares in Q4 2025, an estimated $873K.
  • Franklin Resources first reported a position in Novavax in Q3 2013 and held it in 44 quarters.
  • Franklin Resources's Novavax position peaked at $442M in Q2 2020.
  • 234 funds tracked by Wall St. Rank held Novavax as of Q4 2025.

Based on Franklin Resources's 13F filing for Q4 2025, filed 11 Feb 2026.